Knight Therapeutics Inc.

12:13 PM EST - Knight Therapeutics Inc. : Reported financial results for its third quarter ended September 30, 2020. Revenues were $45.239 million an increase of $41.209 million over prior-year. Net income for the period was $17.492 million, compared to a net loss of $2.959 million in prior-year. Knight Therapeutics Inc.
shares T.GUD are trading unchanged at $5.41.